# FDA recall D-0302-2015

> **Eisai Inc** · Class III · drug recall initiated 2014-12-05.

## Product

BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Distributed by: Elsai Inc., Woodcliff, NJ 07677 NDC 62856-52960.

## Reason for recall

Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.

## Distribution

Nationwide.

## Key facts

- **Recall number:** D-0302-2015
- **Recalling firm:** Eisai Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-12-05
- **Report date:** 2014-12-24
- **Termination date:** 2015-05-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Research Triangle Park, NC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0302-2015

## Citation

> AI Analytics. FDA recall D-0302-2015. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0302-2015. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*